BONH
EW icon

Bank of New Hampshire’s Edwards Lifesciences EW Stock Holding History

Bank of New Hampshire’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-165
Closed -$16K – 528
2022
Q2 		$16K Hold
165
– – ﹤0.01% 427
2022
Q1 		$19K Buy
+165
New +$18.5K ﹤0.01% 427

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New Hampshire's EW Position: Q3 2022 in Review

Bank of New Hampshire sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 165 shares — an estimated $16K sold.

Bank of New Hampshire first reported a position in EW in Q1 2022 and held it in 2 quarters. The position peaked at $19K in Q1 2022. 1,247 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • Bank of New Hampshire reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
  • Bank of New Hampshire sold 165 Edwards Lifesciences shares in Q3 2022, an estimated $16K.
  • Bank of New Hampshire first reported a position in Edwards Lifesciences in Q1 2022 and held it in 2 quarters.
  • Bank of New Hampshire's Edwards Lifesciences position peaked at $19K in Q1 2022.
  • 1,247 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Bank of New Hampshire's 13F filing for Q3 2022, filed 24 Oct 2022.